v3.26.1
Segment Information (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
USD ($)
segment
Dec. 31, 2024
USD ($)
Segment Reporting    
Product revenue, net $ 642 $ 2,266
Cost of goods sold 164 2,143
Research and development costs:    
Total research and development costs 30,251 30,435
Selling, general and administrative costs:    
Total selling, general and administrative costs 20,494 34,492
Restructuring costs 194 2,441
Total operating expenses 51,103 69,511
Other (income) expense    
Interest expense 16,984 15,129
Interest income (1,066) (2,602)
Other (income) expense, net 3,518 (20,173)
Net Income (Loss) $ (69,897) (59,599)
Number of operating segments | segment 1  
Number of reportable segments | segment 1  
Adjustments and reconciling items    
Other (income) expense    
Net Income (Loss) $ 0 0
Single reportable segment | Operating segments    
Segment Reporting    
Product revenue, net 642 2,266
Cost of goods sold 164 2,143
Research and development costs:    
Personnel and related costs 7,196 9,796
Non-cash stock-based compensation 426 2,251
Professional fees 4,004 5,067
Clinical trials expense 15,433 9,384
Chemical, manufacturing and controls cost 1,807 1,927
Other expenses 1,385 2,010
Total research and development costs 30,251 30,435
Commercial costs:    
Personnel and related costs 369 2,516
Non-cash stock-based compensation   (401)
Professional fees 188 554
Commercial and marketing 407 1,389
Travel related expenses 28 309
Other expenses (98) 906
Total commercial costs 894 5,273
Selling, general and administrative costs:    
Personnel and related costs 3,547 5,340
Non-cash stock-based compensation 2,341 4,306
Professional fees 10,120 15,583
Travel related expenses 489 446
Other expenses 3,103 3,544
Total selling, general and administrative costs 19,600 29,219
Total operating expenses 51,103 69,511
Other (income) expense    
Interest expense 16,984 15,129
Interest income (1,066) (2,602)
Other (income) expense, net 3,518 (20,173)
Net Income (Loss) $ (69,897) $ (59,599)